Corrigendum to: Post-treatment neutrophil to lymphocyte ratio as a prognostic tool in patients treated with tocilizumab for severe COVID-19 pneumonia - a single center experience

Biochem Med (Zagreb). 2023 Oct 15;33(3):031201. doi: 10.11613/BM.2023.031201.

Marija Gomerčić Palčić^{1

2}, Hana Matijaca³, Ivan Kruljac⁴, Lucija Vusić^{1

2

3

4

5

6

7

8

9}, Vedran Hostić⁵, Luka Vrbanić², Fanika Mrsić⁶, Radovan Zrilić⁷, Ivana Ćelap⁸, Petar Gaćina^{3

9}

¹ School of Medicine, University of Zagreb, Zagreb, Croatia.
² Department of Internal Medicine, Sestre milosrdnice University Hospital Center, Division of Pulmonology, Zagreb, Croatia.
³ Department of Internal Medicine, Sestre milosrdnice University Hospital Center, Division of Hematology, Zagreb, Croatia.
⁴ Solmed Group, Department: Poliklinika Solmed, Zagreb, Croatia.
⁵ Department of Anesthesiology, Intensive Care Medicine and Pain Management, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
⁶ Department of Internal Medicine, Sestre milosrdnice University Hospital Center, Division of Clinical Immunology and Rheumatology, Zagreb, Croatia.
⁷ Polyclinic for Respiratory Diseases, Dom zdravlja Zagreb - Zapad, Zagreb, Croatia.
⁸ Department of Clinical Chemistry, Sestre milosrdnice University Hospital Center, Croatia.
⁹ School of Dental Medicine, University of Zagreb, Zagreb, Croatia.

Abstract

[This corrects the article DOI: 10.11613/BM.2023.020704.].

Croatian Society of Medical Biochemistry and Laboratory Medicine.